UnitedHealth Group announced impressive second-quarter earnings that significantly surpassed expectations, leading the company to raise its full-year profit forecast. The largest private health insurer in the U.S. now anticipates adjusted earnings of $19.50 to $20 per share for 2026, an increase from its previous estimate of over $18.25. The company is sustaining its revenue guidance of more than $439 billion for the year, with Chief Financial Officer Wayne DeVeydt expressing confidence that results will exceed this target following the strong performance in the second quarter.
Despite this positive earnings growth, DeVeydt noted that medical costs remain elevated compared to historical levels, a challenge the insurance industry has faced for over two years. He emphasized that the company’s improved results are the result of proactive measures to manage these costs rather than a shift in underlying trends.
In comparison with Wall Street expectations, UnitedHealth reported adjusted earnings per share of $6.38, exceeding the anticipated $4.90, and revenue of $112.03 billion, surpassing estimates of $110.85 billion. Following the announcement, the company’s stock experienced a jump of approximately 7% in premarket trading.
The company’s turnaround strategy includes restructuring, leadership changes, and investing $1.5 billion in artificial intelligence to enhance efficiency and patient care. Although this transformation is yielding strong earnings, DeVeydt highlighted that it is a multi-year journey.
UnitedHealthcare’s membership has declined to 48.5 million, with DeVeydt forecasting further losses in enrollment due to affordability concerns stemming from rising healthcare costs. Nonetheless, the medical benefit ratio improved to 86.7%, indicating that the company is collecting more in premiums than it dispenses in benefits.
Why this story matters
Key takeaway
Opposing viewpoint
